Literature DB >> 3461931

Wolfram syndrome: report of four new cases and a review of literature.

L Fishman, R M Ehrlich.   

Abstract

The Wolfram, or DIDMOAD, syndrome consists of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes mellitus usually occurs as the first manifestation of this syndrome, followed by the development of optic atrophy, neurosensory hearing loss, and finally diabetes insipidus. We report on four cases with a review of the literature. The diabetes mellitus occurring in these patients is clinically indistinguishable from classic type I diabetes mellitus. Two of three patients continue to have measurable C-peptide secretion 8 yr after onset of diabetes. Two of three patients with Wolfram syndrome had the HLA-DR2 antigen. Combining our cases with those described in the literature, 7 of 11 patients have the HLA-DR2 antigen. The preponderance of the HLA-DR2 antigen in the Wolfram syndrome is different from classic type I diabetes. This is further evidence of the genetic heterogeneity of diabetes mellitus. Although the Wolfram syndrome is rare, it should be considered in diabetic patients with unexplained optic atrophy and hearing loss or with polyuria and polydipsia in the presence of adequate blood sugar control.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3461931     DOI: 10.2337/diacare.9.4.405

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Juvenile diabetes and visual impairment: Wolfram syndrome.

Authors:  A K Annamalai; S Ellard; M Shanmugam; T P Jai Juganya; E De Franco
Journal:  QJM       Date:  2019-10-01

2.  DIDMOAD syndrome in a Chinese male with HLA DR7 DRw12.

Authors:  J C Chan; J Woo; C S Cockram; R Teoh
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

3.  Wolfram syndrome: a clinical study of two cases.

Authors:  L Van den Bergh; T Zeyen; J Verhelst; C Mahler
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Growth hormone deficiency and empty sella in DIDMOAD syndrome: an endocrine study.

Authors:  A T Soliman; B Bappal; A Darwish; A Rajab; M Asfour
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

5.  Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype.

Authors:  Julia Rohayem; Christian Ehlers; Bärbel Wiedemann; Reinhard Holl; Konrad Oexle; Olga Kordonouri; Giuseppina Salzano; Thomas Meissner; Walter Burger; Edith Schober; Angela Huebner; Min Ae Lee-Kirsch
Journal:  Diabetes Care       Date:  2011-05-20       Impact factor: 19.112

6.  DIDMOAD syndrome: a family with three affected siblings.

Authors:  A Varghese; B A Sims
Journal:  Ulster Med J       Date:  1991-04

7.  Diabetes mellitus, diabetes insipidus, optic atrophy, and deafness: A case of Wolfram (DIDMOAD) syndrome.

Authors:  Nasrollah Maleki; Bahman Bashardoust; Anahita Zakeri; Azita Salehifar; Zahra Tavosi
Journal:  J Curr Ophthalmol       Date:  2016-01-02

8.  Wolfram Syndrome presenting with optic atrophy and diabetes mellitus: two case reports.

Authors:  Masoud Reza Manaviat; Maryam Rashidi; Seyed Mohammad Mohammadi
Journal:  Cases J       Date:  2009-12-19

9.  A Challenging Form of Non-autoimmune Insulin-Dependent Diabetes in a Wolfram Syndrome Patient with a Novel Sequence Variant.

Authors:  Liliana P Paris; Yoshihiko Usui; Josefina Serino; Joaquim Sá; Martin Friedlander
Journal:  J Diabetes Metab       Date:  2015-06

10.  Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes.

Authors:  A Zmyslowska; W Fendler; A Szadkowska; M Borowiec; M Mysliwiec; A Baranowska-Jazwiecka; M Buraczewska; M Fulmanska-Anders; B Mianowska; I Pietrzak; D Rzeznik; W Mlynarski
Journal:  Acta Diabetol       Date:  2015-04-29       Impact factor: 4.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.